Medical Economics Final

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/39

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

40 Terms

1
New cards

Studies that measure the costs of treating an illness using clinical measurements as the treatment's outcome variable are referred to as the:

a)cost-effectiveness analysis

3 multiple choice options

2
New cards

Studies that are designed to measure the costs of treating an illness on the basis of the preference equivalents of the treatment's outcomes are referred to as the:

b)cost utility analysis

3 multiple choice options

3
New cards

Studies that are directly compare the costs of treatment options for an illness with the assumption that all the outcomes of the treatment options are equivalent referred to as the:

c)cost-minimization analysis

3 multiple choice options

4
New cards

______________ analysis relies on careful selection of outcome measures for meaningful comparison of alternative therapies

a)cost-effectiveness

3 multiple choice options

5
New cards

Therapeutic measures of effectiveness in ___________ analysis rely on the selection of therapeutic measure/outcome

a)cost-effectiveness

3 multiple choice options

6
New cards

In ___________ analysis, alternative therapies may have different costs as well as different levels of effectiveness, so it uses the ratio of outcome achieved to cost expended

a)cost-effectiveness

3 multiple choice options

7
New cards

_______________ analysis is a specialization of cost-effectiveness analysis

b)cost utility

3 multiple choice options

8
New cards

______________ analysis quantifies the value individual places on the health and well-being

b)cost utility

3 multiple choice options

9
New cards

____________ analysis in not a technique for driving down expenditures, but provides for a comparison of costs for alternative interventions with equivalent outcomes

c)cost-minimization

3 multiple choice options

10
New cards

As a member of a medical team, you are asked to help decide whether a new antihyperlipidemic medicine or a new long-acting asthma control medication will improve the quality of life for the greatest number of the patients at the least cost. To resolve this issue, you suggest conducting:

c)Cost utility analysis

3 multiple choice options

11
New cards

Suppose the clinical investigators want to compare different protease inhibitors (to treat viral infection) on cost per death averted. The investigators will most likely use the following ratio to evaluate the success of each therapy:

a)cost/effectiveness

2 multiple choice options

12
New cards

The following can be considered to be beneficial based on the benefit to cost ratio:

c)benefit/cost>1

3 multiple choice options

13
New cards

Cost-effectiveness ratios are calculated as the:

c)difference between the total cost of the treatment and the current standard divided by the difference in effectiveness of the treatment and the current standard

3 multiple choice options

14
New cards

You are reading a clinical study evaluating two different treatments for chronic obstructive pulmonary disease

(COPD). You note that the authors have attempted to account for all costs relevant to all parties and that the outcomes of the study are measured using the visual analog scale (like Likert scale). This information tells you that:

a)the study was conducted from the societal perspective using cost-utility analysis

3 multiple choice options

15
New cards

Cost Utility Analysis (CUA) differs from Cost Effective Analysis (CEA) in that:

c)CUA considers changes in both length and quality of life

3 multiple choice options

16
New cards

A physician wishes to test multiple drugs for the treatment of depression, for both their clinical and humanistic outcomes, prior to their inclusion in the formulary (list of approved drugs to be prescribed from). Ideally, the formulary manager must use the following types of pharmacoeconomic analyses to make decisions about formulary inclusion of these drugs

a)cost effective analysis and cost utility analysis

2 multiple choice options

17
New cards

A cost-effectiveness study comparing two alternatives for the treatment of asthma was conducted. The incremental cost-effectiveness ratio of drug Á in comparison to drug B was reported to be $50/symptom-free day. Which one of the following is the best interpretation of this ratio?

c)it costs an additional $50 for every symptom-free day gained by using drug A.

3 multiple choice options

18
New cards

What is the problem with the utility measure in Cost Utility Analysis?

e)all of the above: it's controversial, poorly understood, lacks good definition, and difficult to measure directly

19
New cards

Decision analysis is most useful for making decisions

d)all of the above: under conditions of uncertainty, when there is not a clearly superior course of action, and when tradeoffs must be made among alternate courses of action

20
New cards

You can use 'Cost Effectiveness Analysis' to compare between two different medications for the treatment of the same disease like "high blood pressure".

a)true

2 multiple choice options

21
New cards

Cost-utility analysis is only useful when comparing two or more healthcare interventions having the same outcome (e.g. number of myocardial infarctions prevented), while cost-benefit analysis allows the comparison of two or more health care interventions with entirely different outcomes.

b)false

2 multiple choice options

22
New cards

_______________ is an appropriate evaluation method to use when the case for an intervention has been established and the programs or procedures under consideration have the same, or similar, outcomes.

a)cost-minimization analysis

3 multiple choice options

23
New cards

Cost-effectiveness analysis (CEA) refers to the comparison in which both the inputs and the outcomes are measured in monetary values.

b)false

2 multiple choice options

24
New cards

Cost-minimization analysis (CMA) is a comparison in which inputs are measured in monetary values and outcomes are assumed to be identical.

a)true

2 multiple choice options

25
New cards

Cost-utility analysis (CUA) is a comparison in which inputs are measured in non-monetary units and outcomes are measured as patient preference-weighted extension of life.

b)false

2 multiple choice options

26
New cards

Quality-adjusted life years (QALY) is the outcome measured as life years gained adjusted (weighted) by patient preferences for various health states.

a)true

2 multiple choice options

27
New cards

"Symptom-free days" is the outcome measure used to indicate how many days an individual has symptoms related to the disease of interest.

b)false

2 multiple choice options

28
New cards

Prozac, Amazic (a made-up named drug), and Cecazac (a made-up named drug) are drugs used to treat depression.

They are equally effective in the treatment of depression, and they have the same side-effect profiles. However, their costs differ substantially. Which economic technique should be used to compare them?

a)cost-minimization analysis

3 multiple choice options

29
New cards

What is the outcome/effectiveness measure most commonly used in cost utility analyses?

c)quality-adjusted life years saved

3 multiple choice options

30
New cards

Quality Adjusted Life Years (QALY) combines morbidity and mortality in one effectiveness measure

a)true

2 multiple choice options

31
New cards

It is estimated that the average patient will live for 10 years after a heart attack. Assume that patients would trade 1 year of life in the kind of health experienced after a heart attack for 0.75 years of good health. How many quality-adjusted life years can a patient expect to experience after a heart attack

b)7.5 QALYs

3 multiple choice options

32
New cards

Disability Adjusted Life Years (DALYs) for a disease are years:

c) a and b-of life lost due to premature mortality (YLL) in the population and lost due to disability (YLD) for incident cases of the health condition

3 multiple choice options

33
New cards

Decision analysis is an application of an analytical method that systematically compares different decision options.

a)true

2 multiple choice options

34
New cards

What is the probability of using an antibiotic for patients treated with "Flu-wonder"?

b)0.05

3 multiple choice options

35
New cards

What is the expected number of sick days for a patient treated symptomatically?

b)6.3 days

3 multiple choice options

36
New cards

How many sick days would a patient treated with "Flu-wonder" experience if he required hospitalization?

c)10.0

3 multiple choice options

37
New cards

37: Based on the decision analis, which agent is more effective at minimizing sick days?

a)flu-wonder

2 multiple choice options

38
New cards

The expected cost (to the nearest dollar) for treating a patient for pain with tramadone is:

c)$448

3 multiple choice options

39
New cards

The value of X in Figure # 2 is:

b)0.20

3 multiple choice options

40
New cards

The "O" symbol in Figure # 2 is:

b)chance mode

3 multiple choice options